Cidara Therapeutics Inc (CDTX)
20.68
+3.23
(+18.51%)
USD |
NASDAQ |
Nov 22, 16:00
21.31
+0.63
(+3.05%)
After-Hours: 20:00
Cidara Therapeutics Shareholders Equity (Quarterly): 115.63M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 115.63M |
| June 30, 2024 | 130.94M |
| March 31, 2024 | -17.78M |
| December 31, 2023 | -8.21M |
| September 30, 2023 | 8.038M |
| June 30, 2023 | 15.41M |
| March 31, 2023 | 26.84M |
| December 31, 2022 | -14.44M |
| September 30, 2022 | 9.067M |
| June 30, 2022 | -7.961M |
| March 31, 2022 | 4.957M |
| December 31, 2021 | 21.57M |
| September 30, 2021 | -1.158M |
| June 30, 2021 | 15.79M |
| March 31, 2021 | 1.892M |
| December 31, 2020 | 10.72M |
| September 30, 2020 | 29.55M |
| June 30, 2020 | 41.35M |
| March 31, 2020 | 53.75M |
| December 31, 2019 | 37.84M |
| Date | Value |
|---|---|
| September 30, 2019 | 48.96M |
| June 30, 2019 | 31.78M |
| March 31, 2019 | 43.86M |
| December 31, 2018 | 59.14M |
| September 30, 2018 | 69.93M |
| June 30, 2018 | 82.14M |
| March 31, 2018 | 50.92M |
| December 31, 2017 | 59.74M |
| September 30, 2017 | 50.57M |
| June 30, 2017 | 61.26M |
| March 31, 2017 | 75.99M |
| December 31, 2016 | 88.18M |
| September 30, 2016 | 73.92M |
| June 30, 2016 | 84.81M |
| March 31, 2016 | 95.08M |
| December 31, 2015 | 103.91M |
| September 30, 2015 | 112.62M |
| June 30, 2015 | 120.86M |
| March 31, 2015 | -17.53M |
| December 31, 2014 | -11.44M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-17.78M
Minimum
Mar 2024
130.94M
Maximum
Jun 2024
23.69M
Average
13.06M
Median
Shareholders Equity (Quarterly) Benchmarks
| Biomarin Pharmaceutical Inc | 5.413B |
| Arbutus Biopharma Corp | 106.89M |
| GlycoMimetics Inc | 11.38M |
| FibroGen Inc | -243.67M |
| Cue Biopharma Inc | 25.37M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 162.33M |
| Total Liabilities (Quarterly) | 46.70M |